Aliases & Classifications for Prostatitis

About this section

Summaries for Prostatitis

About this section
Wikipedia:71 Prostatitis (less commonly prostatosis) is inflammation of the prostate gland. Prostatitis is classified... more...

MalaCards based summary: Prostatitis is related to prostate cancer and prostate cancer, progression and metastasis of, and has symptoms including prostatism An important gene associated with Prostatitis is KLK3 (Kallikrein Related Peptidase 3), and among its related pathways are LDL Oxidation in Atherogenesis and Immune response_MIF-mediated glucocorticoid regulation. The drugs ciprofloxacin and norfloxacin have been mentioned in the context of this disorder. Affiliated tissues include prostate, bone and endothelial, and related mouse phenotypes are Synthetic lethal with MLN4924 (a NAE inhibitor) and digestive/alimentary.

Related Diseases for Prostatitis

About this section

Diseases related to Prostatitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 847)
idRelated DiseaseScoreTop Affiliating Genes
1prostate cancer33.6KLK3, MSMB, NKX3-1, PROS1, TGFB1, VDR
2prostate cancer, progression and metastasis of30.9IL10, IL1B, IL6, TNF, VDR
3ocular cancer30.6CXCL8, IL1B, IL6
4renal oncocytoma29.9IL1B, IL6, TGFB1, TNF
5papillary cystadenocarcinoma29.8IL10, TGFB1
6alopecia29.2CXCL8, IL10, IL6, TNF
7churg-strauss syndrome29.1IL10, TGFB1, TNF
8cauda equina syndrome28.9IL10, IL6, TNF
9hypospadias28.8IL10, TNF, VDR
10echinococcosis28.7IL1B, IL6, TGFB1
11hypothyroidism28.6IL1B, IL6, TNF
12hepatitis b28.5CXCL8, IL10, TNF
13lymphedema28.5IL10, IL6, TGFB1, TNF
14congenital bilateral absence of vas deferens28.4CXCL8, IL1B, IL6, TGFB1, TNF
15addison's disease28.3CXCL8, IL10, TGFB1, TNF
16sinusitis28.3CXCL8, IL1B, TGFB1, TNF
17lateral sclerosis28.0CXCL8, IL1B, IL6, TNF
18malignant giant cell tumor28.0CXCL8, IL1B, IL6, TNF
19bacteriuria27.8CXCL8, IL10, IL1B, IL6, TNF
20retroperitoneal fibrosis27.7IL10, IL1B, IL6, TGFB1, TNF
21evans' syndrome27.6CXCL8, IL10, IL1B, TNF
22pyoderma gangrenosum27.5IL10, IL1B, IL6, TGFB1, TNF
23myocardial infarction27.5IL10, IL1B, IL6, PDE5A, TGFB1, TNF
24diphtheria27.4CXCL8, IL10, IL1B, IL6, TNF
25lymphangioma27.2CXCL8, IL10, IL1B, IL6, TNF
26atherosclerosis27.0CXCL8, IL10, IL1B, IL6, TGFB1, TNF
27gingivitis26.8CXCL8, IL10, IL1B, IL6, TGFB1, TNF
28rheumatoid arthritis26.7CXCL8, IL10, IL1B, IL6, TGFB1, TNF
29prostate disease12.3
30prostate cancer 112.2
31prostate adenocarcinoma12.1
32prostate stromal sarcoma12.1
33prostate rhabdomyosarcoma12.1
34prostate cancer, hereditary, 1312.1
35prostate cancer, hereditary, 212.1
36prostate sarcoma12.1
37prostate leiomyosarcoma12.1
38prostate cancer, hereditary, 1212.1
39prostate cancer, hereditary, 1112.1
40prostate angiosarcoma12.1
41prostate embryonal rhabdomyosarcoma12.0
42prostate calculus12.0
43prostatic adenoma12.0
44prostatic hypertrophy11.9
45adenosquamous prostate carcinoma11.9
46atrophy of prostate11.9
47prostate small cell carcinoma11.9
48prostate lymphoma11.9
49prostatic cyst11.8
50prostate carcinoma in situ11.8

Comorbidity relations with Prostatitis via Phenotypic Disease Network (PDN):


Acute CystitisBladder Neck Obstruction
Coronary Artery DiseaseIschemic Heart Disease
Prostate CancerProstatic Hypertrophy
Epididymo-OrchitisProstate Calculus
Urethral StrictureUrinary Tract Obstruction

Graphical network of the top 20 diseases related to Prostatitis:



Diseases related to prostatitis

Symptoms & Phenotypes for Prostatitis

About this section

UMLS symptoms related to Prostatitis:


prostatism

GenomeRNAi Phenotypes related to Prostatitis according to GeneCards Suite gene sharing:

26
idDescriptionGenomeRNAi Source AccessionScoreTop Affiliating Genes
1GR00250-A-14.0ADRA1A, CXCL8, IL10, IL1B, TGFB1, TNF

MGI Mouse Phenotypes related to Prostatitis according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053818.6IL10, IL6, NKX3-1, TGFB1, TNF, VDR
2MP:00053798.3IL10, IL6, MSMB, NKX3-1, TGFB1, TNF
3MP:00053898.3IL10, IL6, MSMB, NKX3-1, TGFB1, TNF
4MP:00107718.2IL10, IL1B, IL6, PROS1, TGFB1, TNF
5MP:00020068.1IL10, IL1B, IL6, MSMB, NKX3-1, TGFB1
6MP:00053908.0IL10, IL1B, IL6, NKX3-1, TGFB1, TNF
7MP:00053697.9ADRA1A, IL10, IL6, PROS1, TGFB1, TNF
8MP:00053857.4ADRA1A, IL10, IL1B, IL6, PROS1, TGFB1

Drugs & Therapeutics for Prostatitis

About this section

Drugs for Prostatitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 178)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
AcetaminophenapprovedPhase 4978103-90-21983
Synonyms:
4'-Hydroxyacetanilide
4'-hydroxyacetanilide
4-(Acetylamino)phenol
4-Acetamidophenol
4-Acetaminophenol
4-Hydroxyacetanilide
4-Hydroxyanilid kyseliny octove
4-acetamidophenol
A-Per
A.F. Anacin
AC1Q1KYJ
AC1Q1KYK
APAP
Abenol
Abensanil
Abrol
Abrolet
Acamol
Accu-Tap
Acenol
Acephen
Acertol
Aceta Elixir
Aceta Tablets
Acetaco
Acetagesic
Acetalgin
Acetaminofen
Acetaminophen
Acetaminophen Uniserts
Acetamol
Acetavance
Acetofen
Actamin
Actamin Extra
Actamin Super
Actifed Plus
Actimol
Actimol Chewable Tablets
Actimol Children'S Suspension
Actimol Infants' Suspension
Actimol Junior Strength Caplets
Actron
Afebrin
Afebryl
Aferadol
Algesidal
Algina
Algomol
Algotropyl
Allay
Alpiny
Alpinyl
Alvedon
Amadil
Aminofen
Aminofen Max
Anacin
Anacin 3
Anacin-3
Anacin-3 Extra Strength
Anadin dla dzieci
Anaflon
Analter
Anapap
Andox
Anelix
Anexsia
Anexsia 10/660
Anexsia 5/325
Anexsia 7.5/325
Anexsia 7.5/650
Anhiba
Anoquan
Anti-Algos
Antidol
Anuphen
Apacet
Apacet Capsules
Apacet Elixir
Apacet Extra Strength Caplets
Apacet Extra Strength Tablets
Apacet Regular Strength Tablets
Apadon
Apamid
Apamide
Apitrelal
Apo-Acetaminophen
Arfen
Arthralgen
Asetam
Asomal
Aspac
Aspirin Free Anacin Maximum Strength Caplets
Aspirin Free Anacin Maximum Strength Gel Caplets
Aspirin Free Anacin Maximum Strength Tablets
Aspirin-Free Anacin
Aspirin-Free Excedrin Caplets
Asplin
Atasol
Atasol Caplets
Atasol Drops
Atasol Forte Caplets
Atasol Forte Tablets
Atasol Oral Solution
Atasol Tablets
Atralidon
Babikan
Bacetamol
Bancap
Bancap Hc
Banesin
Bayer Select
Bayer Select Allergy-Sinus
Bayer Select Head Cold
Bayer Select Headache Pain
Bayer Select Maximum Strength Headache Pain Relief Formula
Bayer Select Menstrual Multi-Symptom
Bayer Select Sinus Pain Relief
Ben-u-ron
Benmyo
Bickie-mol
Biocetamol
Bucet
Butalbital
Butapap
CCRIS 3
CHEBI:46195
Cadafen
Calapol
Calmanticold
Calonal
Calpol
Capital
Capital with Codeine
Captin
Causalon
Cefalex
Cetadol
Children'S Acetaminophen Elixir Drops
Children'S Acetaminophen Oral Solution
Children'S Tylenol Chewable
Claradol Codeine
Clixodyne
Co-Gesic
Cod-Acamol Forte
Codabrol
Codalgin
Codapane
Codicet
Codisal
Codisal Forte
Codoliprane
Codral Pain Relief
Cofamol
Conacetol
Contac Cough & Sore Throat Formula
Contra-Schmerz P
Coricidin
Coricidin D
Coricidin Sinus
Cosutone
Croix Blanche
Cuponol
Curadon
Curpol
Custodial
D oliprane
Dafalgan
Dapa
Dapa X-S
Darocet
Darvocet
Darvocet-N 50
Datril
Datril Extra-Strength
Daygrip
Demilets
Deminofen
Democyl
Demogripal
Desfebre
Dhamol
Dhc Plus
Dial-a-gesic
Dial-alpha-gesic
Dimindol
Dirox
Disprol
Dol-Stop
Dolcor
Dolefin
Dolegrippin
Dolene AP-65
Dolene Ap-65
Dolgesic
Doliprane
Dolko
Dolofugin
Doloreduct
Dolorfug
Dolorol Forte
Dolorstop
Dolotec
Dolprone
Dorocoff
Dresan
Dristan Cold No Drowsiness
Dristancito
Drixoral Plus
Duaneo
Dularin
Duorol
Duracetamol
Duradyne Dhc
Durapan
Dymadon
Dymadon Co
Dymadon Forte
Dypap
Ecosetol
Elixodyne
Empracet
Endecon
Enelfa
Eneril
Esgic
Esgic-Plus
Eu-Med
Excedrin
Excedrin Caplets
Excedrin Extra Strength Caplets
Excipain
Exdol
Exdol Strong
Fanalgic
Farmadol
Febranine
Febrectal
Febrectol
Febrex
Febricet
Febridol
Febrilix
Febrin
Febrinol
Febro-Gesic
Febrolin
Femcet
Fendon
Fensum
Fepanil
Fever All
Feverall
Feverall Junior Strength
Feverall Sprinkle Caps Junior Strength
Fevor
Finimal
Finiweh
Fioricet
Fluparmol
Fortalidon P
Freka-cetamol
Gattaphen T
Gelocatil
Geluprane
Genapap
Genapap Children'S Elixir
Genapap Children'S Tablets
Genapap Extra Strength Caplets
Genapap Extra Strength Tablets
Genapap Regular Strength Tablets
Genebs
Genebs Extra Strength Caplets
Genebs Regular Strength Tablets
Genebs X-Tra
Geralgine-P
Gripin Bebe
Grippostad
Gynospasmine
Hedex
Helon N
Homoolan
Hy-Phen
Hycomine Compound
Hydrocet
Ildamol
Inalgex
Infadrops
Infants' Feverall
Influbene N
Injectapap
Intensin
Janupap
Jin Gang
Junior Disprol
KBio1_000660
Kataprin
Kinder Finimal
Korum
Kratofin simplex
L024125
Labamol
Lekadol
Lemgrip
Lemsip
Lestemp
Liqiprine
Liquagesic
Liquigesic Co
Liquiprin
Liquiprin Children'S Elixir
Liquiprin Infants" Drops
Lonarid
Lonarid Mono
Lorcet-Hd
Lortab
Lupocet
Lyteca
Lyteca Syrup
Magnidol
Malex N
Malgis
Malidens
Maxadol
Medigesic Plus
Medinol Paediatric
Medocodene
Melabon Infantil
Mexalen
Midol Maximum Strength
Midol PM Night Time Formula
Midol Regular Strength
Midol Teen Formula
Migraleve Yellow
Minafen
Minoset
Miralgin
Momentum
Mono Praecimed
 
Multin
N-(4-Hydroxyphenyl)acetamide
N-Acetyl-4-aminophenol
N-Acetyl-p-aminophenol
N-acetyl-p-aminophenol
NAPA
NCX 701
NEBS
NSC3991
Naldegesic
Napafen
Napap
Naprinol
Nealgyl
Nebs
Neo-Fepramol
NeoCitran
Neodol
Neodolito
Neopap
Neotrend
Neuridon
New Cortal for Children
NilnOcen
Nina
No-Febril
Nobedon
Nodolex
Noral
Norcet
Norco
O-Acetaminophenol
Ofirmev
Oltyl
Oralgan
Oraphen-PD
Ortensan
Oxycet
Oxycocet
Oxycodone 2.5/Apap 500
Oxycodone 5/Apap 500
PCM Paracetamol Lichtenstein
Paceco
Pacemo
Pacemol
Pacet
Pacimol
Paedialgon
Paedol
Painex
Paldesic
Pamol
Panacete
Panadeine
Panadeine Co
Panadiene
Panado-Co
Panado-Co Caplets
Panadol
Panadol Extra Strength
Panadol Junior Strength Caplets
Panadol Maximum Strength Caplets
Panadol Maximum Strength Tablets
Panale ve
Panaleve
Panamax
Panasorb
Panasorbe
Panets
Panex
Panodil
Panofen
Pantalgin
Papa-Deine
Papa-Deine #3
Papa-Deine #4
Para-Suppo
Para-Tabs
Paracemol
Paracenol
Paracet
Paracetamol
Paracetamol AL
Paracetamol Antipanin P
Paracetamol BC
Paracetamol Basics
Paracetamol DC
Paracetamol Dr. Schmidgall
Paracetamol Fecofar
Paracetamol Genericon
Paracetamol Hanseler
Paracetamol Harkley
Paracetamol Heumann
Paracetamol Hexal
Paracetamol Italfarmaco
Paracetamol Nycomed
Paracetamol PB
Paracetamol Raffo
Paracetamol Ratiopharm
Paracetamol Rosch
Paracetamol Saar
Paracetamol SmithKline Beecham
Paracetamol Stada
Paracetamol Winthrop
Paracetamol von ct
Paracetamole
Paracetamolo
Paracetamolum
Paracetanol
Paracetol
Paracin
Paracod
Paracodol
Paracétamol
Parador
Paradrops
Parakapton
Parake
Paralen
Paralief
Paralink
Paralyoc
Paramol
Paramolan
Paranox
Parapan
Parasedol
Parasin
Paraspen
Parcetol
Parelan
Parmol
Parogal
Paroma
Pasolind
Pasolind N
Pe-Tam
Pediapirin
Pediatrix
Pedric
Percocet
Percocet-5
Percocet-Demi
Percogesic with Codeine
Perdolan Mono
Perfalgan
Phenaphen
Phenaphen Caplets
Phenaphen W/Codeine
Phendon
Phenipirin
Phogoglandin
Phrenilin
Phrenilin Forte
Pinex
Piramin
Pirinasol
Plicet
Polmofen
Predimol
Predualito
Prestwick_13
Prodol
Prompt
Prontina
Propacet
Propacet 100
Proval #3
Puernol
Pulmofen
Pyregesic-C
Pyrigesic
Pyrinazine
Pyromed
Quiet World
Redutemp
Reliv
Remedol
Rhinex D-Lay Tablets
Rivalgyl
Robigesic
Robitussin Night Relief
Rockamol Plus
Rounox
Roxicet
Roxicet 5/500
Roxilox
RubieMol
Rubophen
Rupemol
SK-Apap
SPBio_002836
Salzone
Sanicet
Sanicopyrine
Scanol
Scentalgyl
Scherzatabletten Rezeptur 534
Schmerzex
Sedalito
Sedapap
Semolacin
Servigesic
Seskamol
Setakop
Setamol
Setol
Sifenol
Sinaspril
Sine-Off Sinus Medicine Caplets
Sinedol
Sinmol
Sinubid
Snaplets-FR
Spalt N
Spalt fur die nacht
St Joseph Aspirin-Free
St Joseph Aspirin-Free for Children
St. Joseph Cold Tablets for Children
St. Joseph Fever Reducer
Stanback
Stopain
Sudafed Severe Cold Formula
Sudafed Sinus
Sunetheton
Supac
Supadol mono
Supofen
Suppap
Suppap-120
Suppap-325
Suppap-650
Supramol-M
Synalgos-Dc-A
TYL
Tabalgin
Tachiprina
Talacen
Tapanol
Tapanol Extra Strength Caplets
Tapanol Extra Strength Tablets
Tapar
Tavist Allergy/Sinus/Headache
Tazamol
Temlo
Tempanal
Tempra
Tempra Caplets
Tempra Chewable Tablets
Tempra D.S
Tempra Drops
Tempra Syrup
Tencon
Termacet
Termalgin
Termalgine
Termofren
TheraFlu
Tibinide
Tibizide
Tiffy
Tisin
Tisiodrazida
Titralgan
Tizide
Tocris-1706
Toximer P
Tralgon
Treupel N
Treupel mon
Treuphadol
Triad
Triaminic Sore Throat Formula
Triaprin
Tricoton
Tussapap
Ty lenol
Tycolet
Tylenol
Tylenol (TN)
Tylenol Allergy Sinus
Tylenol Arthritis Extended Relief
Tylenol Caplets
Tylenol Children'S Chewable Tablets
Tylenol Children'S Elixir
Tylenol Children'S Suspension Liquid
Tylenol Drops
Tylenol Elixir
Tylenol Extra Strength Adult Liquid Pain Reliever
Tylenol Extra Strength Caplets
Tylenol Extra Strength Gelcaps
Tylenol Extra Strength Tablets
Tylenol Gelcaps
Tylenol Infants Drops
Tylenol Infants" Suspension Drops
Tylenol Junior Strength Caplets
Tylenol Junior Strength Chewable Tablets
Tylenol Regular Strength Caplets
Tylenol Regular Strength Tablets
Tylenol Tablets
Tylex
Tylex CD
Tylol
Tylox
Tylox-325
Tymol
Ultracet
Upsanol
Utragin
Valadol
Valgesic
Valorin
Valorin Extra
Vanquish
Veralgina
Vermidon
Verpol
Viclor Richet
Vicodin
Vicodin Es
Vicodin Hp
Vips
Viruflu
Vivimed
Volpan
Wygesic
Zatinol
Zolben
acetaminofén
acétaminophène
alpha-Per
p-(Acetylamino)phenol
p-Acetamidophenol
p-Acetaminophenol
p-Acetylaminophenol
p-Hydroxyacetanilide
p-Hydroxyphenolacetamide
p-acetamidophenol
p-acetaminophenol
p-hydroxy-acetanilid
p-hydroxyacetanilide
p-hydroxyphenolacetamide
2
CycloserineapprovedPhase 410668-41-7401, 6234
Synonyms:
(+)-4-Amino-3-isoxazolidinone
(+)-Cycloserine
(4R)-4-Amino-3-isoxazolidinone
(4R)-4-amino-1,2-oxazolidin-3-one
(4R)-4-aminoisoxazolidin-3-one
(R)-(+)-4-Amino-3-isoxazolidinone
(R)-(+)-Cycloserine
(R)-4-AMINO-ISOXAZOLIDIN-3-ONE
(R)-4-AMINO-isoxazolidin-3-one
(R)-4-Amino-3-isoxazolidinone
(R)-4-Amino-3-isoxazolidone
(R)-Cycloserine
1pb9
3-Isoxazolidinone, 4-amino-, (+)- (8CI)
3-Isoxazolidinone, 4-amino-, (4R)- (9CI)
3-Isoxazolidinone, 4-amino-, (R)
3-Isoxazolidinone, 4-amino-, D
30020_FLUKA
30020_SIGMA
4-27-00-05549 (Beilstein Handbook Reference)
4AX
68-41-7
AB00443920
AC-4721
AC1L1M33
AC1Q4UA7
AI3-50153
BB_NC-1631
BIDD:GT0707
BPBio1_001252
BRN 0080798
BSPBio_001138
BSPBio_002121
C 3909
C-9390
C-9400
C08057
C3909_SIGMA
C3H6N2O2
C6880_SIGMA
C7670_SIGMA
CAS-339-72-0
CAS-68-41-7
CHEBI:40009
CHEMBL771
CID6234
CPD-2482
CPD000058313
Cicloserina
Cicloserina [INN-Spanish]
Cicloserina [Italian]
Closerin
Closina
Cyclo-D-serine
Cyclorin
Cycloserine
Cycloserine (JP15/USP/INN)
Cycloserine [INN:BAN:JAN]
Cycloserinum
Cycloserinum [INN-Latin]
D-(+)-Cycloserine
D-4-Amino-3-isossazolidone
D-4-Amino-3-isossazolidone [Italian]
D-4-amino-3-Isoxazolidinone
D-4-amino-3-Isoxazolidone
D-4-amino-3-isoxazolidinone
D-4-amino-3-isoxazolidone
D-CS
D-Cycloserine
D-Cycloserine synth. BP 88
D-Cycloserine, synthetic
D-Oxamicina
D-Oxamycin
D-amino-3-isoxazolidinone
D-cycloserine
D00877
DB03123
DCS
DL-Cycloserine
DRG-0195
DivK1c_000098
E-733-A
EINECS 200-688-4
 
EU-0100252
FA6C7F8B-D080-4EA3-978F-1ECFB5A29D09
Farmiserina
HMS1571I20
HMS1920C06
HMS2051C15
HMS2091I14
HMS500E20
HSDB 3218
I-1431
IDI1_000098
K-300
KBio1_000098
KBio2_001340
KBio2_003908
KBio2_006476
KBio3_001341
KBioGR_000890
KBioSS_001340
L-Cycloserine
LMPK14000007
LS-86757
Lopac-C-1159
Lopac-C-3909
Lopac-C-7005
Lopac0_000252
MLS000758215
MLS001423962
Micoserina
Miroserina
Miroseryn
MolPort-000-858-643
NCGC00015213-01
NCGC00015213-02
NCGC00015213-03
NCGC00016306-01
NCGC00016306-02
NCGC00016306-03
NCGC00016306-05
NCGC00093713-01
NCGC00093713-02
NINDS_000098
NSC 154851
Novoserin
Orientomycin
Oxamicina
Oxamicina [Italian]
Oxamycin
PA 94
PA-94
Prestwick0_001089
Prestwick1_001089
Prestwick2_001089
Prestwick3_001089
R(+)-4-Amino-3-isoxazolidinone
R-(+)-Cycloserine
R-4-Amino-3-isoxazolidinone
RO-1-9213
Ro-1-9213
S1998_Selleck
SAM001247014
SAM002264599
SC-49088
SMP1_000167
SMR000058313
SPBio_000008
SPBio_003029
SPECTRUM1500215
Seromycin
Seromycin (TN)
Spectrum2_000084
Spectrum3_000371
Spectrum4_000305
Spectrum5_000797
Spectrum_000860
Tebemicina
Tisomycin
UNII-95IK5KI84Z
Wasserina
alpha-Cycloserine
cyclo-D-Serine
cycloserine
orientomycin
α-Cycloserine
3
AcetylcholineapprovedPhase 4, Phase 3, Phase 277651-84-3187
Synonyms:
ACh
Acetyl choline ion
Acetylcholine Chloride
Acetylcholine cation
 
Acetylcholinium: acetyl-Choline
Choline acetate
Choline acetate (ester)
O-Acetylcholine
acetylcholine chloride
4
CefoxitinapprovedPhase 43635607-66-0441199
Synonyms:
(6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7S)-3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7S)-3-[(carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7S)-3-{[(aminocarbonyl)oxy]methyl}-7-(methyloxy)-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
3-[(carbamoyloxy)methyl]-7alpha-methoxy-7beta-[(2-thienylacetyl)amino]-3,4-didehydrocepham-4-carboxylate
3-[(carbamoyloxy)methyl]-7alpha-methoxy-7beta-[(thiophen-2-yl)acetamido]-3,4-didehydrocepham-4-carboxylic acid
33564-30-6
35607-66-0
AB00513931
AC-1303
AC1L9AQF
AC1L9SPP
BIDD:GT0505
BPBio1_000863
BSPBio_000783
BSPBio_003101
C06887
C08106
CEFOXITIN SODIUM
CFX
CHEBI:209807
CHEBI:53655
CHEMBL1200530
CHEMBL996
CID441199
CID441392
CPD-9233
CPD000058809
Cefoxitin
Cefoxitin (USAN/INN)
Cefoxitin sodium (JAN/USP)
Cefoxitin sodium salt
Cefoxitina
Cefoxitine
Cefoxitinum
Ceftoxitin
Cephoxitin
D00913
D02345
DB01331
 
DivK1c_000576
HMS1570H05
HMS1921F14
HMS2092P11
HMS501M18
IDI1_000576
KBio1_000576
KBio2_001879
KBio2_004447
KBio2_007015
KBio3_002601
KBioGR_000626
KBioSS_001879
MLS000028557
MLS001076334
MLS002222151
Mefoxin
Mefoxin (TN)
Mefoxitin
MolPort-003-666-398
NCGC00093351-02
NCGC00093351-03
NINDS_000576
Prestwick0_000832
Prestwick1_000832
Prestwick2_000832
Prestwick3_000832
Prestwick_12
Rephoxitin
SAM002564251
SMR000058809
SPBio_000771
SPBio_002704
SPECTRUM1502031
Spectrum 001399
Spectrum2_000676
Spectrum3_001491
Spectrum4_000153
Spectrum5_001145
Spectrum_001399
ZINC03830449
cefoxitin
5
ImipenemapprovedPhase 45074431-23-5104838
Synonyms:
(5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid
(5R,6S)-3-(2-Formimidoylamino-ethylsulfanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(5R,6S)-3-[2-(aminomethylideneamino)ethylsulfanyl]-6-[(1R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(5R,6S)-6-((R)-1-Hydroxyethyl)-3-(2-(iminomethylamino)ethylthio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carbonsaeure
(5R,6S)-6-[(1R)-1-hydroxyethyl]-3-({2-[(iminomethyl)amino]ethyl}thio)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
64221-86-9
6623-14-9
74431-23-5
AC-528
AC1L2XLB
AR-1A6479
Ambap64221-86-9
BIDD:GT0686
BPBio1_000525
BSPBio_000477
C06665
CHEBI:143934
CHEBI:471744
CHEMBL148
CHEMBL373477
CID104838
CPD-9231
D04515
DB01598
HMS1569H19
 
HMS2090A15
IMP
Imipemide
Imipenem
Imipenem (INN)
Imipenem anhydrous
Imipenem, N-Formimidoyl thienamycin
Imipenem, N-formimidoyl thienamycin
Imipenem, n-formimidoyl thienamycin
Imipenemum
KST-1A7214
N-Formimidoyl thienamycin
N-Formimidoylthienamycin
N-formimidoylthienamycin
NCGC00167958-01
NCGC00167958-02
NCGC00167958-03
NSC717864
Prestwick0_000519
Prestwick1_000519
Prestwick2_000519
Prestwick3_000519
Prestwick_844
SPBio_002398
Tienamycin
[5R-[5.alpha.,6.alpha.(R*)]]-6-(1-Hydroxyethyl)-3-[[2- [(iminomethyl)amino]ethyl]thio]-7-oxo-1-azabicyclo[3.2.0]hept-2- ene-2-carboxylic acid monohydrate
imipenem
6
CefotaximeapprovedPhase 43663527-52-6456256, 5742673
Synonyms:
(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
60846-21-1
63527-52-6
63527-53-7
64485-93-4 (mono-hydrochloride salt)
AC-217
AC1L1E42
AC1L9UKL
AC1NSF5T
AC1NSF6T
AC1NUIF8
AC1NX3QV
AC1NZU9Q
AC1O712I
AC1O7G8N
AC1OC9NB
AKOS003286450
BIDD:GT0681
BPBio1_000240
BRD-K78364995-236-03-5
BRD-K99586414-236-02-3
BSPBio_000218
BSPBio_001961
C06885
C16H17N5O7S2
CE3
CHEBI:204928
CHEMBL102
CID2632
CID456256
CID5361298
CID5361354
CID5479527
CID5742673
CID5916965
CID6540461
CID6604086
CID6914272
CID7566336
CID9868614
Cefotaxim
Cefotaxim Hikma
Cefotaxim Hikma (TN)
Cefotaxima
Cefotaxima [INN-Spanish]
 
Cefotaxime (INN)
Cefotaxime [INN:BAN]
Cefotaxime acid
Cefotaxime sodium
Cefotaximum
Cefotaximum [INN-Latin]
Cephotaxim
Cephotaxime
Claforan
Claforan (*Sodium salt*)
Céfotaxime
D07647
DB00493
DivK1c_000767
EINECS 264-299-1
HMS2090M11
IDI1_000767
KBio1_000767
KBio2_000548
KBio2_003116
KBio2_005684
KBio3_001181
KBioGR_000736
KBioSS_000548
Klaforan
LS-149920
LS-187246
Lopac0_000278
MolPort-002-339-742
MolPort-005-934-578
MolPort-006-834-754
NCGC00021126-01
NINDS_000767
Prestwick0_000139
Prestwick1_000139
Prestwick2_000139
Prestwick3_000139
RU 24662
Ru-24756
SPBio_000138
SPBio_002157
STK383264
Spectrum2_000119
Spectrum3_000331
Spectrum4_000268
Spectrum5_000667
Spectrum_000108
UNII-N2GI8B1GK7
cefotaxime
7
CilastatinapprovedPhase 43082009-34-55280454, 6435415
Synonyms:
(2Z)-7-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-2-({[(1S)-2,2-dimethylcyclopropyl]carbonyl}amino)hept-2-enoic acid
(L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid
(Z)-(S)-6-Carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine
(Z)-(S)-6-carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine
(Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid
(Z)-7-[(2R)-2-amino-3-hydroxy-3-oxopropyl]sulfanyl-2-[[(1S)-2,2-dimethylcyclopropanecarbonyl]amino]hept-2-enoic acid
81129-83-1 (mono-hydrochloride salt)
82009-34-5
AC-268
AC1O5JQX
BIDD:GT0782
C01675
C16H26N2O5S
CHEBI:3697
CHEMBL766
CID6435415
Cilastatin
Cilastatin (INN)
 
Cilastatin Monosodium Salt
Cilastatin [INN:BAN]
Cilastatin acid
Cilastatina
Cilastatina [Spanish]
Cilastatine
Cilastatine [French]
Cilastatinum
Cilastatinum [Latin]
D07698
DB01597
EINECS 279-875-8
LS-74560
MK-791
MK0791
MolPort-003-987-260
NCGC00181346-01
TL8005438
UNII-141A6AMN38
8
Testosteroneapproved, investigationalPhase 454658-22-06013
Synonyms:
(+)-testosterone
(+-)-8-iso-testosterone
(+-)-retrotestosterone
(+-)-testosterone
(17b)-17-hydroxy-androst-4-en-3-one
(17beta)-17-Hydroxyandrost-4-en-3-one
(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
13-Iso-testosterone
17-Hydroxy-(17-beta)-androst-4-en-3-one
17-Hydroxy-(17beta)-androst-4-en-3-one
17-Hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one
17-Hydroxy-D4-androsten-3-one
17-Hydroxy-androst-4-en-3-one
17-beta-Hydroxy-delta(sup 4)-androsten-3-one
17-beta-Hydroxyandrost-4-en-3-one
17?-Hydroxy-4-androsten-3-one
17a-Hydroxy-(13a)-androst-4-en-3-one
17a-Hydroxy-13a-androst-4-en-3-one
17a-Hydroxy-14b-androst-4-en-3-one
17a-Hydroxy-androst-4-en-3-one
17b-Hydroxy-(10a)-androst-4-en-3-one
17b-Hydroxy-(13a)-androst-4-en-3-one
17b-Hydroxy-(8a)-androst-4-en-3-one
17b-Hydroxy-(8a,10a)-androst-4-en-3-one
17b-Hydroxy-(9b)-androst-4-en-3-one
17b-Hydroxy-(9b,10a)-androst-4-en-3-one
17b-Hydroxy-13a-androst-4-en-3-one
17b-Hydroxy-8a-androst-4-en-3-one
17b-Hydroxy-D4-androsten-3-one
17b-Hydroxy-androst-4-en-3-on
17b-Hydroxy-androst-4-en-3-one
17b-Hydroxyandrost-4-en-3-one
17b-Hydroxyandrost-4-ene-3-one
17b-Testosterone
17b-hydroxy-4-androsten-3-one
17beta-Hydroxy-3-oxo-4-androstene
17beta-Hydroxy-4-androsten-3-one
17beta-Hydroxy-delta(sup4)-androsten-3-one
17beta-Hydroxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-ene-3-one
17beta-hydroxy-4-androsten-3-one
4-Androsten-17?-ol-3-one
4-Androsten-17beta-ol-3-one
4-Androsten-3-one-17b-ol
4-androsten-17β-ol-3-one
4-androstene-17beta-ol-3-one
46923_FLUKA
46923_RIEDEL
58-22-0
7-beta-Hydroxyandrost-4-en-3-one
8-Iso-testosterone
9b,10a-Testosterone
9b-Testosterone
AA 2500
AC-14899
AC1L1LM0
Andriol
Andro
Andro 100
Andro L.A. 200
AndroGel
Androderm
Androderm (TN)
Androgel
Androgel (TN)
Android 10
Android 25
Android 5
Androlin
Andronaq
Andronate 100
Andronate 200
Andropatch
Andropository 200
Androsorb
Androst-4-en-17b-ol-3-one
Androst-4-en-17beta-ol-3-one
Androst-4-ene-17b-ol-3-one
Andrusol
Andryl 200
B5DEE83F-632B-48A1-A0ED-A51E7F13DF2E
BIDD:ER0555
BIM-0061761.0001
Beta Testosterone
Bio-0678
Bio-T-Gel
C00535
CCRIS 574
CDB 111C
CHEBI:17347
CHEMBL386630
CID6013
CMC_13449
COL 1621
CP 601B
CPD000058344
Cristerona T
Cristerone T
D00075
D4-Androsten-17b-ol-3-one
DB00624
Dea No. 4000
Delatest
Delatestryl
Depo-Testadiol
Depo-Testosterone
Depo-Testosterone Cypionate
Depotest
EINECS 200-370-5
Epitestosteron
Everone 200
Geno-Cristaux Gremy
Geno-cristaux Gremy
Geno-cristaux gremy
HMS2052N11
HSDB 3398
Halotensin
Homosteron
Homosterone
 
Intrinsa
LMST02020002
LS-148813
LibiGel
Libigel
Lumitestosteron
MLS000563091
MLS001032098
MLS001306401
MLS002174283
Malerone
Malestrone
Malestrone (amps)
Malogen in Oil
Malogen, Aquaspension Injection
Malogen, aquaspension injection
Mertestate
Metandren
Methyltestosterone
MolPort-002-506-901
NCGC00091018-01
NSC 9700
Neo-Hombreol F
Neo-Testis
Neo-testis
Neotestis
Oreton
Oreton F
Oreton Methyl
Oreton-F
Orquisteron
Perandren
Percutacrine Androgenique
Percutacrine androgenique
Primotest
Primoteston
Rac-17b-hydroxy-(13a)androst-4-en-3-one
Rac-17b-hydroxy-(8a)-androst-4-en-3-one
Rac-17b-hydroxy-(9b,10a)androst-4-en-3-one
Rac-17b-hydroxy-androst-4-en-3-one
Relibra
Retrotestosterone
S00309
S2033_Selleck
SAM001246921
SMR000058344
SMR001261453
Scheinpharm Testone-Cyp
Striant
Striant (TN)
Sustanon
Sustanone
Sustason 250
Synandrol F
T-Cypionate
T1500_SIGMA
T5411_FLUKA
T5411_SIGMA
TES
Teslen
Testamone 100
Testandrone
Testaqua
Testiculosterone
Testim
Testim (TN)
Testobase
Testoderm
Testoderm Tts
Testogel
Testoject-50
Testolent
Testolin
Testopel Pellets
Testopropon
Testosteroid
Testosteron
Testosterona
Testosterona [INN-Spanish]
Testosterone
Testosterone (JAN/USP)
Testosterone Cypionate
Testosterone Enanthate
Testosterone Hydrate
Testosterone [Androgenic steroids, anabolic]
Testosterone [INN:BAN]
Testosterone and its esters
Testosterone hydrate
Testosterone solution
Testosteronum
Testosteronum [INN-Latin]
Testostosterone
Testostérone
Testoviron
Testoviron Schering
Testoviron T
Testoxyl
Testred
Testred Cypionate 200
Testrin-P.A
Testro AQ
Testro Aq
Testrone
Testryl
Tostrelle
Tostrex
Trans-Testosterone
UNII-3XMK78S47O
Viatrel
Virilon
Virilon IM
Virormone
Virosterone
ZINC06500184
beta testosterone
delta(sup 4)-Androsten-17(beta)-ol-3-one
delta4-Androsten-17beta-ol-3-one
delta4-androsten-17b-ol-3-one
testosterone
trans-Testosterone
9
MethyltestosteroneapprovedPhase 454658-18-46010
Synonyms:
17(alpha)-Methyl-delta(4)-androsten-17(beta)-ol-3-one
17-Methyltestosterone
17-beta-Hydroxy-17-methylandrost-4-en-3-one
17-methyltestosterone
17alpha-Methyl-3-oxo-4-androsten-17beta-ol
17alpha-Methyl-delta(4)-androsten-17beta-ol-3-one
17alpha-Methyltestosterone
17alpha-methyl-delta-androsten-17beta-ol-3-one
17alpha-methyltestosterone
 
17beta-Hydroxy-17-methylandrost-4-en-3-one
17α-methyl-Δ4-androsten-17β-ol-3-one
17α-methyltestosterone
4-Androstene-17alpha-methyl-17beta-ol-3-one
Android
Methyltestosterone
Methyltestosteronum
Metiltestosterona
NSC-9701
Testred
Virilon
10
Gabapentinapproved, investigationalPhase 428960142-96-33446
Synonyms:
1-(Aminomethyl)-cyclohexaneacetic acid
1-(Aminomethyl)cyclohexaneacetic acid
2-[1-(aminomethyl)cyclohexyl]acetic acid
60142-96-3
AC-1485
AC1L1FYE
AC1Q53PH
AKOS000280865
Aclonium
Apo-Gabapentin
Apotex brand of gabapentin
Aventis brand of gabapentin
BB_SC-1512
BIDD:GT0656
BPBio1_000993
BRN 2359739
BSPBio_000901
C040029
C9H17NO2
CAS-60142-96-3
CCRIS 7210
CHEBI:188316
CHEBI:42797
CHEMBL940
CI 945
CI-945
CID3446
D00332
DB00996
DDS-2003
DM-1796
DM-5689
EINECS 262-076-3
EU-0100582
G-154
G0318
G154_SIGMA
GBN
GOE 2450
Gabapen
Gabapentin
Gabapentin (JAN/USAN/INN)
Gabapentin GR
Gabapentin Hexal
Gabapentin Stada
Gabapentin [USAN:INN:BAN]
Gabapentin-ratiopharm
Gabapentina
Gabapentine
Gabapentine [INN-French]
Gabapentino
Gabapentino [INN-Spanish]
Gabapentino [Spanish]
Gabapentinum
 
Gabapentinum [INN-Latin]
Gabapetin
Go 3450
Goe-3450
HMS1570N03
HMS2089J03
HSDB 7364
Hexal brand of gabapentin
I06-0677
L000733
LS-7194
Lopac-G-154
Lopac0_000582
MLS000069358
MolPort-000-883-862
NCGC00015466-01
NCGC00015466-02
NCGC00015466-06
NCGC00015466-09
NCGC00016891-01
NCGC00021545-02
NCGC00021545-04
NCGC00021545-05
NSC742194
Neurontin
Neurontin (TN)
Novo-Gabapentin
Novo-Gabapentine
Novopharm brand of gabapentin
PMS-Gabapentin
Parke Davis brand of gabapentin
Pfizer brand of gabapentin
Pharmascience brand of gabapentin
Prestwick0_000861
Prestwick1_000861
Prestwick2_000861
Prestwick3_000861
Prestwick_151
S2133_Selleck
SMR000058311
SPBio_002822
STK598009
Serada
Stadapharm brand of gabapentin
TL8003814
Tocris-0806
UNII-6CW7F3G59X
Vultin
Warner-Lambert brand of gabapentin
[1-(AMINOMETHYL)CYCLOHEXYL]ACETIC ACID
gabapentin
gabapentin (Neurontin)
gabapentina
gabapentinium
ratiopharm brand of gabapentin
11Calcium, DietaryPhase 4, Phase 35525
12Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 222776
13Cholinergic AgentsPhase 4, Phase 3, Phase 23846
14Central Nervous System DepressantsPhase 4, Phase 3, Phase 2, Phase 112806
15Tranquilizing AgentsPhase 4, Phase 34164
16calcium channel blockersPhase 4, Phase 31940
17AnalgesicsPhase 4, Phase 3, Phase 211287
18Anti-Anxiety AgentsPhase 4, Phase 31816
19Psychotropic DrugsPhase 4, Phase 36279
20Neurotransmitter AgentsPhase 4, Phase 3, Phase 217734
21AnticonvulsantsPhase 4, Phase 32620
22Anti-Bacterial AgentsPhase 4, Phase 3, Phase 210884
23HormonesPhase 4, Phase 3, Early Phase 113979
24Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 3, Early Phase 112767
25Hormone AntagonistsPhase 4, Phase 3, Early Phase 112778
26AndrogensPhase 4, Phase 3, Early Phase 11275
27PermixonPhase 4, Phase 311
28Anti-Infective AgentsPhase 4, Phase 3, Phase 2, Phase 121402
29FluoroquinolonesPhase 4388
30Renal AgentsPhase 4, Phase 3732
31AntimetabolitesPhase 411774
32Nucleic Acid Synthesis InhibitorsPhase 44855
33PrulifloxacinPhase 47
34Topoisomerase InhibitorsPhase 4, Phase 3, Phase 24945
35abobotulinumtoxinAPhase 4, Phase 3, Phase 2626
36Antitubercular AgentsPhase 41272
37Neuromuscular AgentsPhase 4, Phase 3, Phase 21129
38onabotulinumtoxinAPhase 4, Phase 3, Phase 2626
39incobotulinumtoxinAPhase 4, Phase 3, Phase 2635
40Botulinum Toxins, Type APhase 4, Phase 3, Phase 2630
41Antibiotics, AntitubercularPhase 4, Phase 3, Phase 26972
42Botulinum ToxinsPhase 4, Phase 3, Phase 2669
43Antimanic AgentsPhase 4790
44GABA AgentsPhase 41622
45
protease inhibitorsPhase 45320
Synonyms:
 
protease inhibitors
46HIV Protease InhibitorsPhase 45319
47Pharmaceutical SolutionsPhase 4, Phase 37793
48Antineoplastic Agents, HormonalPhase 45407
49Anabolic AgentsPhase 4499
50Testosterone 17 beta-cypionatePhase 4546

Interventional clinical trials:

(show top 50)    (show all 63)
idNameStatusNCT IDPhase
1Treatment of Chronic Bacterial ProstatitisCompletedNCT02130713Phase 4
2Treating Urological Chronic Pelvic Pain Syndrome (UCPPS) PainCompletedNCT02385266Phase 4
3Impact of Six Patient Information Leaflets (PIL) on Doctor Patient CommunicationCompletedNCT02246361Phase 4
4Botox as a Treatment for Interstitial Cystitis in WomenCompletedNCT00194610Phase 4
5Evaluation of the Non-inferiority of Cefoxitin Versus Imipenem/Cilastatin in the Treatment of Urinary Tract Infections Caused by ESBL-producing Escherichia ColiRecruitingNCT02474706Phase 4
6TRT on BPH Hypoganadal MetS Patients. Florence-PROTESTActive, not recruitingNCT02366975Phase 4
7Effectiveness of Sympathetic Plexus Block on Male Pelvic Pain (Prostatitis, Prostatodynia)SuspendedNCT00194636Phase 4
8Trial of Viagra' in Men With Chronic Pelvic Pain Syndrome Type IIITerminatedNCT00194597Phase 4
9Botox as a Treatment for Chronic Male Pelvic Pain SyndromeTerminatedNCT00194623Phase 4
10Efficacy of Gralise® for Chronic Pelvic PainTerminatedNCT01678911Phase 4
11Efficacy & Safety Study of Pregabalin to Treat Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)Unknown statusNCT00371033Phase 3
12Efficacy Study of Acupuncture to Relieve Symptoms of Chronic ProstatitisCompletedNCT00260637Phase 2, Phase 3
13Efficacy Study of a Standardized Pollen Extract Preparation (Cernilton) to Treat Inflammatory Chronic Prostatitis-Chronic Pelvic Pain Syndrome (CP-CPPS)CompletedNCT00919893Phase 3
14An Effectiveness and Safety Study for Levofloxacin in Chronic ProstatitisCompletedNCT00402688Phase 3
15A Study to Evaluate the Safety and Effectiveness of Levofloxacin Compared With Ciprofloxacin in Patients With Chronic Bacterial ProstatitisCompletedNCT00236808Phase 3
16Levofloxacin, Chronic Bacterial ProstatitisCompletedNCT00277511Phase 3
17Trial to Compare Alfuzosin Versus Placebo in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain SyndromeCompletedNCT00103402Phase 3
18Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA)CompletedNCT00169585Phase 3
19Complementary and Alternative Medicine for Urological Symptoms(CAMUS)CompletedNCT00603304Phase 3
20"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased RiskCompletedNCT00056407Phase 3
21JALYN for Benign Prostatic Hyperplasia (BPH) and Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)TerminatedNCT01830829Phase 3
22Botulinum Toxin Type A for the Treatment of Male Chronic Pelvic Pain SyndromeTerminatedNCT00464373Phase 3
23Laparoscopic Prostatectomy for Chronic ProstatitisUnknown statusNCT00775515Phase 2
24Use of Silodosin to Treat Moderate to Severe Abacterial Chronic Prostatitis/Chronic Pelvic Pain Syndrome.CompletedNCT00740779Phase 2
25An Open-Label Study of CC-10004 for Chronic Prostatitis/Chronic Pelvic Pain SyndromeCompletedNCT00701311Phase 2
26Botox for Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)CompletedNCT00529386Phase 2
27An Efficacy And Safety Study Of Tanezumab For The Treatment Of Pain Associated With Chronic Abacterial ProstatitisCompletedNCT00826514Phase 2
28A Clinical Study to Investigate the Efficacy, Safety and Pharmacokinetics of ASP3652 in Patients With Chronic Abacterial Prostatitis / Chronic Pelvic Pain Syndrome (CP/CPPS)CompletedNCT01391338Phase 2
29An Effectiveness and Safety Study of ELMIRON (Pentosan Polysulfate Sodium) for the Treatment of Chronic Non-Bacterial Inflammation of the Prostate GlandCompletedNCT00236990Phase 2
30A Pilot Study of Norfloxacin for Hepatopulmonary SyndromeCompletedNCT00362752Phase 2
31Intravesical Epirubicin Plus BCG to Prevent the Recurrence of Transitional Cell Carcinoma of BladderCompletedNCT00343356Phase 2
32Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate)CompletedNCT00037141Phase 1, Phase 2
33Use of Autologous Adipose-Derived Stem/Stromal Cells (AD-cSVF) in Symptomatic Benign Prostate HypertrophyRecruitingNCT02961114Phase 1, Phase 2
34Open-Label Study of Thalidomide for Chronic Prostatitis/Chronic Pelvic PainTerminatedNCT00301405Phase 2
35Efficacy Study of Tamsulosin and Tolterodine Treatment for Chronic ProstatitisUnknown statusNCT00913315
36Efficacy of Extracorporal Shock Wave Therapy in Patient With Chronic Non-bacterial Prostatitis / Chronic Pelvic Pain SyndromeUnknown statusNCT01714830
37Genetic Study of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)Unknown statusNCT00499317
38Non Interventional Study of Levofloxacin in Chronic ProstatitisCompletedNCT02711943
39Efficacy of Electromagnetic Stimulation Therapy for Chronic Prostatitis and Chronic Pelvic Pain SyndromeCompletedNCT00922012
40Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic ProstatitisCompletedNCT01098279
41Clinical Efficacy of Roxithromycin in Men With Chronic Prostatitis/Chronic Pelvic Pain SyndromeCompletedNCT01843946
42Configuration of a New Prostate Disease Nomogram Predicting Prostate Biopsy OutcomeCompletedNCT01826617
43Role of Residual Urine and Asymptomatic Prostatitis in the Development of Urinary Tract Infections in Spinal Cord InjuryCompletedNCT01601041
44Diagnostic Challenges in IC (and Male CPPS)CompletedNCT00672087
452013 Annual National Digital Rectal Exam (DRE) Day StudyCompletedNCT01886547
46Linkage Analysis in Interstitial CystitisCompletedNCT00675298
47Observational Study of Control Participants for the MAPP Research NetworkCompletedNCT01098292
48Physical Therapy Trial for Pelvic PainCompletedNCT00434343
49Sono-Electro-Magnetic Therapy for Refractory Chronic Pelvic Pain SyndromeCompletedNCT00710073
50Combined Sono-electro-magnetic Therapy for Treatment of Refractory Chronic Pelvic Pain SyndromeCompletedNCT00688506

Search NIH Clinical Center for Prostatitis

Inferred drug relations via UMLS68/NDF-RT46:


Cochrane evidence based reviews: prostatitis

Genetic Tests for Prostatitis

About this section

Anatomical Context for Prostatitis

About this section

MalaCards organs/tissues related to Prostatitis:

36
Prostate, Bone, Endothelial, Testes, Lymph node, Lung, T cells

Publications for Prostatitis

About this section

Articles related to Prostatitis:

(show top 50)    (show all 21070)
idTitleAuthorsYear
1
Human herpesvirus 8 infection contributes to a T helper 2 immune response in men from Tobago with prostate cancer. (27734534)
2017
2
A lifestyle intervention among elderly men on active surveillance for non-aggressive prostate cancer: a randomised feasibility study with whole-grain rye and exercise. (28086943)
2017
3
Prostate Artery Embolization for Complete Urinary Outflow Obstruction Due to Benign Prostatic Hypertrophy. (27853823)
2017
4
Practical Polling for Prostate Cancer: AR-V7-based Treatment Selection. (28089303)
2017
5
Management of Prostate Cancer in Elderly Patients: Recommendations of a Task Force of the International Society of Geriatric Oncology. (28089304)
2017
6
Risk of lymph node metastases in pathological gleason scorea8o6 prostate adenocarcinoma: Analysis of institutional and population-based databases. (27692833)
2017
7
Treatment of men with high-risk prostate cancer based on race, insurance coverage, and access to advanced technology. (28089387)
2017
8
Reply to Thomas Zilli, Gilles Crehange and Olivier Chapet's Letter to the Editor re: Pascal Rischmann, Albert Gelet, Benjamin Riche, et al. Focal High Intensity Focused Ultrasound of Unilateral Localized Prostate Cancer: A Prospective Multicentric Hemiablation Study of 111 Patients. Eur Urol 2017;71:267-73. (28089305)
2017
9
mTUEPA: Trans-Urethral Monopolar Enucleation of Prostatic Adenoma. Preliminary Report. (28087281)
2017
10
Bringing clarity or confusion? The role of prostate-specific membrane antigen positron-emission/computed tomography for primary staging in prostate cancer. (28090758)
2017
11
Active Surveillance of Prostate Cancer. (28090626)
2017
12
Tumor suppressor SPOP ubiquitinates and degrades EglN2 to compromise growth of prostate cancer cells. (28089830)
2017
13
Xanthogranulomatous Prostatitis, a Rare Prostatic Entity. (27800297)
2017
14
High frequency of osteonecrosis of the jaw among denosumab-treated prostate cancer patients. (27921521)
2017
15
Changes in the Level of Circulating hsa-miR-297 and hsa-miR-19b-3p miRNA Are Associated with Generalization of Prostate Cancer. (28091918)
2017
16
Multi-institutional Analysis Shows that Low PCAT-14 Expression Associates with Poor Outcomes in Prostate Cancer. (27460352)
2017
17
Chronic Prostatitis Affects Male Reproductive Health and Is Associated with Systemic and Local Epigenetic Inactivation of C-X-C Motif Chemokine 12 Receptor C-X-C Chemokine Receptor Type 4. (27760433)
2017
18
Overexpression of Aquaporin-1 is a Prognostic Factor for Biochemical Recurrence in Prostate Adenocarcinoma. (27817002)
2017
19
Regulation of Docetaxel Sensitivity in Prostate Cancer Cells by Hsa-miR-125A-3P via Modulation of MTA1 Signaling. (28088556)
2017
20
Magnolin inhibits prostate cancer cell growth in vitro and in vivo. (28092770)
2017
21
The addition of a sagittal image fusion improves the prostate cancer detection in a sensor-based MRI /ultrasound fusion guided targeted biopsy. (28086856)
2017
22
Huge Prostatic Utricle with Transitional Cell Carcinoma in an Adult. (28065811)
2017
23
Reply from Authors re: Jens Uwe Stolzenburg, Iason Kyriazis, Evangelos Liatsikos. Postoperative Lymphocele Formation after Pelvic Lymph Node Dissection at the Time of Radical Prostatectomy Should Not Be Considered an Inevitable Consequence of the Approach. Eur Urol 2017;71:159-60: Which Lymphatic Vessels Have To Be Secured During Pelvic Lymph Node Dissection for Prostate Cancer? (27666998)
2017
24
Differentiating tumor heterogeneity in formalin-fixed paraffin-embedded (FFPE) prostate adenocarcinoma tissues using principal component analysis of matrix-assisted laser desorption/ionization imaging mass spectral data. (27791282)
2017
25
Chronic Prostate Inflammation Predicts Symptom Progression in Chronic Prostatitis/Chronic Pelvic Pain (CP/CPPS) Patients. (28089730)
2017
26
Concurrent Diffuse Pyelonephritis and Prostatitis: Discordant Findings on Sequential FDG PET/CT and 67Ga SPECT/CT Imaging. (27824318)
2017
27
Editorial Comment to Assessing clinically significant prostate cancer: Diagnostic properties of multiparametric magnetic resonance imaging compared to three-dimensional transperineal template mapping histopathology. (28087898)
2017
28
Androgen receptor gene polymorphisms and risk of prostate cancer: a meta-analysis. (28091563)
2017
29
Androgen Mediated Regulation of Endoplasmic Reticulum-Associated Degradation and its Effects on Prostate Cancer. (28091582)
2017
30
The Prostate in Female? Clear Cell Adenocarcinoma in a Female Urethral Diverticulum. (27789300)
2017
31
Toxicity and quality of life report of a phase II study of stereotactic body radiotherapy (SBRT) for low and intermediate risk prostate cancer. (28086825)
2017
32
Clinical and Microbiological Features and Factors Associated with Fluoroquinolone Resistance in Men with Community-Acquired Acute Bacterial Prostatitis. (26943143)
2016
33
Quantitative proteomic study of human prostate cancer cells with different metastatic potentials. (26846621)
2016
34
appendix 8: Prostate cancer: eUpdate published online September 2016 (http://www.esmo.org/Guidelines/Genitourinary-Cancers). (27664256)
2016
35
Regulatory T cells control strain specific resistance to Experimental Autoimmune Prostatitis. (27624792)
2016
36
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) activates caspases in human prostate cancer cells through sigma 1 receptor. (26792723)
2016
37
Retraction Note to: Diagnostic investigations of canine prostatitis incidence together with benign prostate hyperplasia, prostate malignancies, and biochemical recurrence in high-risk prostate cancer as a model for human study. (27826942)
2016
38
Transmembrane prostate androgen-induced protein 1 (PMEPA1) promotes the migration and maintains mesenchymal-like phenotype of breast cancer cells]. (26927372)
2016
39
IMAGES IN CLINICAL MEDICINE. Emphysematous Prostatitis. (27579638)
2016
40
The Utility of STAT6 and ALDH1 Expression in the Differential Diagnosis of Solitary Fibrous Tumor vs Prostate Specific Stromal Neoplasms. (27068523)
2016
41
Quality-of-life outcomes from the Prostate Adenocarcinoma: TransCutaneous Hormones (PATCH) trial evaluating luteinising hormone-releasing hormone agonists versus transdermal oestradiol for androgen suppression in advanced prostate cancer. (27753182)
2016
42
Coexistence of 2 malignant urogenital neoplasms: a testicular seminoma and adenocarcinoma of the prostate gland in a patient 1 year after kidney transplantation. (27243345)
2016
43
Intracellular location of BRCA2 protein expression and prostate cancer progression in the Swedish Watchful Waiting Cohort. (26775038)
2016
44
Urine TMPRSS2: ERG Fusion Transcript as a Biomarker for Prostate Cancer: Literature Review. (26774207)
2016
45
Unusual Cushing's Syndrome and Hypercalcitoninaemia due to a Small Cell Prostate Carcinoma. (28044110)
2016
46
Cell line modeling to study biomarker panel in prostate cancer. (26764245)
2016
47
Enhanced expression of LINE-1-encoded ORF2 protein in early stages of colon and prostate transformation. (26716650)
2016
48
Overexpression of Pleomorphic Adenoma Gene-Like 2 Is a Novel Poor Prognostic Marker of Prostate Cancer. (27537362)
2016
49
Intracellular calcium oscillations in strongly metastatic human breast and prostate cancer cells: control by voltage-gated sodium channel activity. (27665102)
2016
50
Prostate tumor overexpressed 1 expression in invasive urothelial carcinoma. (26746655)
2016

Variations for Prostatitis

About this section

Expression for genes affiliated with Prostatitis

About this section
Search GEO for disease gene expression data for Prostatitis.

Pathways for genes affiliated with Prostatitis

About this section

Pathways related to Prostatitis according to GeneCards Suite gene sharing:

(show all 49)
idSuper pathwaysScoreTop Affiliating Genes
19.5IL1B, TNF
29.3CXCL8, IL6, TNF
39.3IL1B, KLK3, TNF
49.3TGFB1, TNF, VDR
5
Show member pathways
9.2CXCL8, IL1B, IL6
69.2CXCL8, IL1B, TNF
79.2IL1B, IL6, TNF
89.2IL1B, IL6, TNF
99.2IL6, TGFB1, TNF
109.1IL10, IL6, TNF
119.1IL1B, IL6, TGFB1
12
Show member pathways
9.1IL1B, IL6, TGFB1
139.0IL1B, TGFB1, TNF
14
Show member pathways
9.0IL10, IL6, TGFB1
158.9IL10, IL1B, TNF
16
Show member pathways
8.9IL10, TGFB1, TNF
178.9IL1B, IL6, TNF, VDR
18
Show member pathways
8.8CXCL8, IL1B, IL6, TNF
19
Show member pathways
8.8CXCL8, IL1B, IL6, TNF
20
Show member pathways
8.8CXCL8, IL1B, IL6, TNF
218.8CXCL8, IL1B, IL6, TNF
22
Show member pathways
8.8CXCL8, IL1B, IL6, TNF
238.7CXCL8, IL1B, IL6, TGFB1
24
Show member pathways
8.6IL1B, IL6, TGFB1, TNF
25
Show member pathways
8.5IL10, IL1B, IL6, TNF
268.5IL10, IL1B, IL6, TNF
278.5IL10, IL1B, IL6, TNF
288.5IL10, IL6, TGFB1, TNF
298.5CXCL8, IL6, KLK3, NKX3-1, TGFB1
30
Show member pathways
8.4IL10, IL1B, TGFB1, TNF
318.3CXCL8, IL1B, IL6, TGFB1, TNF
328.3CXCL8, IL1B, IL6, TGFB1, TNF
338.3CXCL8, IL1B, IL6, TGFB1, TNF
348.2CXCL8, IL10, IL1B, IL6, TNF
35
Show member pathways
8.2CXCL8, IL10, IL1B, IL6, TNF
368.2CXCL8, IL10, IL1B, IL6, TNF
37
Show member pathways
8.1CXCL8, IL10, IL1B, IL6, TGFB1
388.0IL10, IL1B, IL6, TGFB1, TNF
398.0IL10, IL1B, IL6, TGFB1, TNF
40
Show member pathways
8.0IL10, IL1B, IL6, TGFB1, TNF
41
Show member pathways
8.0IL10, IL1B, IL6, TGFB1, TNF
42
Show member pathways
8.0IL10, IL1B, IL6, TGFB1, TNF
437.7CXCL8, IL10, IL1B, IL6, NKX3-1, TNF
447.7IL10, IL1B, IL6, TGFB1, TNF, VDR
457.7CXCL8, IL10, IL1B, IL6, TGFB1, TNF
467.7CXCL8, IL10, IL1B, IL6, TGFB1, TNF
47
Show member pathways
7.7CXCL8, IL10, IL1B, IL6, TGFB1, TNF
48
Show member pathways
7.7CXCL8, IL10, IL1B, IL6, TGFB1, TNF
49
Show member pathways
7.7CXCL8, IL10, IL1B, IL6, TGFB1, TNF

GO Terms for genes affiliated with Prostatitis

About this section

Cellular components related to Prostatitis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1extracellular regionGO:00055768.4CXCL8, IL1B, IL6, KLK3, PROS1, TGFB1
2extracellular spaceGO:00056156.8CXCL8, IL10, IL1B, IL6, KLK3, MSMB

Biological processes related to Prostatitis according to GeneCards Suite gene sharing:

(show top 50)    (show all 57)
idNameGO IDScoreTop Affiliating Genes
1embryonic digestive tract developmentGO:004856610.5CXCL8, TNF
2negative regulation of lipid storageGO:001088810.5IL6, TNF
3positive regulation of chemokine productionGO:003272210.5IL6, TNF
4chronic inflammatory response to antigenic stimulusGO:000243910.3IL1B, TNF
5negative regulation of lipid catabolic processGO:005099510.3IL1B, TNF
6negative regulation of myoblast differentiationGO:004566210.3TGFB1, TNF
7positive regulation of calcidiol 1-monooxygenase activityGO:006055910.3IL1B, TNF
8positive regulation of chemokine biosynthetic processGO:004508010.3IL1B, TNF
9positive regulation of fever generationGO:003162210.3IL1B, TNF
10positive regulation of heterotypic cell-cell adhesionGO:003411610.3IL1B, TNF
11positive regulation of membrane protein ectodomain proteolysisGO:005104410.3IL1B, TNF
12positive regulation of mononuclear cell migrationGO:007167710.3TGFB1, TNF
13positive regulation of protein complex assemblyGO:003133410.3TGFB1, TNF
14cellular response to hepatocyte growth factor stimulusGO:003572910.3IL10, IL6
15defense response to protozoanGO:004283210.3IL10, IL6
16regulation of establishment of endothelial barrierGO:190314010.2IL1B, TNF
17regulation of I-kappaB kinase/NF-kappaB signalingGO:004312210.2IL1B, TNF
18negative regulation of cytokine secretion involved in immune responseGO:000274010.2IL10, TNF
19negative regulation of growth of symbiont in hostGO:004413010.2IL10, TNF
20positive regulation of histone acetylationGO:003506610.2IL1B, TGFB1
21receptor biosynthetic processGO:003280010.1IL10, TNF
22cellular response to interleukin-1GO:007134710.1CXCL8, IL6, NKX3-1
23cellular response to tumor necrosis factorGO:007135610.1CXCL8, IL6, NKX3-1
24response to molecule of bacterial originGO:000223710.1CXCL8, IL10
25sequestering of triglycerideGO:003073010.1IL1B, TNF
26positive regulation of MAP kinase activityGO:004340610.0PDE5A, TGFB1, TNF
27epithelial cell proliferation involved in salivary gland morphogenesisGO:006066410.0IL6, NKX3-1, TNF
28leukocyte migrationGO:005090010.0IL1B, PROS1, TNF
29positive regulation of phagocytosisGO:005076610.0IL1B, PROS1, TNF
30negative regulation of fat cell differentiationGO:004559910.0IL6, TGFB1, TNF
31positive regulation of interleukin-6 productionGO:00327559.9IL1B, IL6, TNF
32positive regulation of nitric oxide biosynthetic processGO:00454299.9IL1B, IL6, TNF
33positive regulation of peptidyl-serine phosphorylationGO:00331389.9IL6, TGFB1, TNF
34positive regulation of protein kinase B signalingGO:00518979.9IL6, TGFB1, TNF
35negative regulation of T cell proliferationGO:00421309.8IL10, PDE5A, TGFB1
36cellular response to organic cyclic compoundGO:00714079.8IL1B, TGFB1, TNF
37lipopolysaccharide-mediated signaling pathwayGO:00316639.8IL1B, TGFB1, TNF
38positive regulation of cell divisionGO:00517819.8IL1B, NKX3-1, TGFB1
39response to glucocorticoidGO:00513849.7IL10, IL6, TNF
40cell growthGO:00160499.6ADRA1A, IL6, TGFB1
41cellular response to lipopolysaccharideGO:00712229.5CXCL8, IL10, IL6, TNF
42response to organic substanceGO:00100339.4IL10, TGFB1, TNF
43positive regulation of apoptotic processGO:00430659.4IL1B, IL6, TGFB1, TNF
44positive regulation of NF-kappaB transcription factor activityGO:00510929.4IL1B, IL6, TGFB1, TNF
45positive regulation of protein phosphorylationGO:00019349.3IL1B, NKX3-1, TGFB1, TNF
46positive regulation of sequence-specific DNA binding transcription factor activityGO:00510919.3IL10, IL1B, IL6, TNF
47protein kinase B signalingGO:00434919.3IL1B, NKX3-1, TGFB1, TNF
48response to lipopolysaccharideGO:00324969.2IL10, IL1B, IL6, PROS1
49positive regulation of ERK1 and ERK2 cascadeGO:00703749.1ADRA1A, IL1B, IL6, TNF
50wound healingGO:00420609.1IL1B, IL6, TGFB1

Molecular functions related to Prostatitis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cytokine activityGO:00051258.0IL10, IL1B, IL6, TGFB1, TNF

Sources for Prostatitis

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet